Literature DB >> 22999509

Cancer of the vulva.

Neville F Hacker1, Patricia J Eifel, Jacobus van der Velden.   

Abstract

Mesh：

Year:  2012        PMID： 22999509     DOI： 10.1016/S0020-7292(12)60021-6

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  14 in total

1.  Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015.

Authors:  H G Schnürch; S Ackermann; C D Alt; J Barinoff; C Böing; C Dannecker; F Gieseking; A Günthert; P Hantschmann; L C Horn; R Kürzl; P Mallmann; S Marnitz; G Mehlhorn; C C Hack; M C Koch; U Torsten; W Weikel; L Wölber; M Hampl
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10       Impact factor: 2.915

2.  Could Harmonic Scalpel (Ultracision®) be considered the best device in surgical treatment of vulvar cancer of patients with implanted pace-maker? Proposal and rationale.

Authors:  Salvatore Gizzo; Alessandra Andrisani; Emanuele Ancona; Michela Quaranta; Amerigo Vitagliano; Marco Noventa; Giovanni Battista Nardelli; Guido Ambrosini
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 3.  Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel.

Authors:  Angela Collarino; Valentina Fuoco; Giorgia Garganese; Lenka M Pereira Arias-Bouda; Germano Perotti; Gianpiero Manca; Sergi Vidal-Sicart; Francesco Giammarile; Lioe-Fee de Geus-Oei; Giovanni Scambia; Alessandro Giordano; Renato A Valdés-Olmos; Marco Maccauro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-02       Impact factor: 9.236

4.  Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience.

Authors:  Siqing Fu; Naiyi Shi; Jennifer Wheler; Aung Naing; Filip Janku; Sarina Piha-Paul; Jing Gong; David Hong; Apostolia Tsimberidou; Ralph Zinner; Vivek Subbiah; Ming-Mo Hou; Pedro Ramirez; Lois Ramondetta; Karen Lu; Funda Meric-Bernstam
Journal:  Gynecol Oncol Res Pract       Date:  2015-11-14

5.  Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer.

Authors:  Sylwia Kellas-Ślęczka; Brygida Białas; Marek Fijałkowski; Piotr Wojcieszek; Marta Szlag; Agnieszka Cholewka; Maciej Ślęczka; Zofia Kołosza
Journal:  J Contemp Brachytherapy       Date:  2016-02-29

6.  Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma.

Authors:  Leonardo Micheletti; Mario Preti; Viviana Cintolesi; Elisabetta Corvetto; Silvana Privitera; Eleonora Palmese; Chiara Benedetto
Journal:  J Gynecol Oncol       Date:  2018-04-13       Impact factor: 4.401

7.  Invasive Paget's disease of the vulva treated with a combination of surgery and concurrent chemoradiotherapy: A case report.

Authors:  Yoshihide Inayama; Kaoru Abiko; Taito Miyamoto; Akihito Horie; Ken Yamaguchi; Tsukasa Baba; Noriomi Matsumura; Sachiko Minamiguchi; Masaki Mandai
Journal:  Mol Clin Oncol       Date:  2018-09-17

8.  Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer.

Authors:  Kim E Kortekaas; Koen K Van de Vijver; Mariëtte I E van Poelgeest; C Blake Gilks; Vincent T H B M Smit; Saimah Arif; Deep Arora; Asma Faruqi; Raji Ganesan; Nicholas R Griffin; Richard Hale; Yelin E Hock; Lars-Christian Horn; W Glenn McCluggage; Pinias Mukonoweshuro; Kay J Park; Brian Rous; Bruce Tanchel; Anne-Sophie Van Rompuy; Gerry van Schalkwyk; Jo Vella; Marco Vergine; Naveena Singh; Tjalling Bosse
Journal:  Int J Gynecol Pathol       Date:  2020-09       Impact factor: 3.326

9.  Trends and Outcomes of Sentinel Lymph Node Biopsy in Early-stage Vulvar Squamous Cell Carcinoma: A Population-based Study.

Authors:  Juan Zhou; Wen-Wen Zhang; Xue-Ting Chen; San-Gang Wu; Jia-Yuan Sun; Qiong-Hua Chen; Zhen-Yu He
Journal:  J Cancer       Date:  2018-04-30       Impact factor: 4.207

10.  Prognostic Value of the Number of Removed Lymph Nodes in Vulvar Squamous Cell Carcinoma Patients With Node-Positive Disease: A Population-Based Study.

Authors:  San-Gang Wu; Wen-Wen Zhang; Jia-Yuan Sun; Qiong-Hua Chen; Zhen-Yu He; Juan Zhou
Journal:  Front Oncol       Date:  2018-05-30       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.